[Form 4] CEL SCI CORP Insider Trading Activity

Rhea-AI Filing Summary

Geert Kersten, listed as Chief Executive Officer and a director of CEL-SCI Corporation (CVM), reported an open-market purchase of 570 shares of CEL-SCI common stock on 09/30/2025 at a price of $9.20 per share. After this transaction the filing shows 73,405 shares beneficially owned directly. The Form 4 was signed on 10/02/2025. The report contains no derivative transactions and includes no additional explanatory disclosures.

Positive

• Insider purchase disclosed: CEO/director acquired 570 shares at $9.20 on 09/30/2025
• Clear ownership after trade: Reporting person beneficially owns 73,405 shares directly

Negative

• None.

Insights

Corporate Insider Analyst

TL;DR: CEO/director purchased shares; transaction is a routine insider buy disclosure.

The filing documents a direct purchase of 570 common shares by Geert Kersten, who is both CEO and a director. This is a straightforward Section 16 disclosure showing increased direct beneficial ownership to 73,405 shares and a per-share price of $9.20.

This type of Form 4 is typically a transparency event rather than a detailed strategic disclosure; it confirms an insider acquired shares but does not include context such as size relative to holdings or intent.

Securities Compliance Officer

TL;DR: Filing meets Section 16 reporting requirements with a dated signature.

The Form 4 records the transaction date of 09/30/2025 and a signed declaration dated 10/02/2025, satisfying the required disclosure of changes in beneficial ownership. No amendments or derivative instruments are reported, and the form includes the reporting person’s address and roles (CEO and director).

This document provides the specific compliance information investors and regulators rely on: exact share count, price, and ownership after the trade.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

KERSTEN GEERT R

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VA 22182

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A		570	A	$9.2	73,405	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Geert Kersten	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for CEL-SCI (CVM)?

The Form 4 was filed by Geert Kersten, who is listed as Chief Executive Officer and a director of CEL-SCI Corporation.

What transaction is reported on the Form 4 for CVM?

The report shows a purchase of 570 shares of CEL-SCI common stock on 09/30/2025 at a price of $9.20 per share.

How many CEL-SCI shares does the reporting person own after the transaction?

After the reported purchase the filing shows 73,405 shares beneficially owned directly by Geert Kersten.

Does the Form 4 report any derivative transactions or amendments?

No. The filing shows only a non-derivative common stock purchase and lists no derivatives or amendments.

When was the Form 4 signed?

The signature block shows the reporting person signed the Form 4 on 10/02/2025.